Rhenman & Partners Asset Management AB »

Alpine Immune Sciences shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.4M 86k 39.64

More positions owned by Rhenman & Partners Asset Management AB

Cigna Corp (CI)
Eli Lilly & Co. (LLY)
Tenet Healthcare Corp Com New (THC)
Boston Scientific Corporation (BSX)
Anthem (ELV)
Abbvie (ABBV)
Hca Holdings (HCA)
Regeneron Pharmaceuticals (REGN)
Cooper Cos (COO)
Merck & Co (MRK)
Becton, Dickinson and (BDX)
Medtronic SHS (MDT)
Oscar Health Cl A (OSCR)
Procept Biorobotics Corp (PRCT)
McKesson Corporation (MCK)

View all positions for Rhenman & Partners Asset Management AB

Top funds holding Alpine Immune Sciences

Decheng Capital
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Franklin Resources

View all funds holding Alpine Immune Sciences